Arcutis gearing up for active 2023
Arcutis Biotherapeutics generated sales from its first treatment during the fourth quarter of 2022, helping usher in a new era for the company. Based in Westlake Village, Arcutis recognized $3 million in revenue for the quarter that ended Dec. 31, all of it coming from its Zoryve cream aimed to treat plaque psoriasis. For the Read More →
Inogen shares nosedive after poor fourth-quarter earnings
Shares of Goleta-based Inogen have nosedived 32% in the days since the company’s fourth quarter and full-year earnings results. Inogen, a maker of portable oxygen containers, announced on Feb. 23 that it suffered a net loss of $56.6 million for the quarter ended Dec. 31, up substantially from a net loss of $22.8 million in Read More →
Olaplex’s struggles continue in fourth quarter
Sales and earnings fell yet again for Olaplex Holdings, a Montecito-based hair products seller, in the fourth quarter of 2022 leading to shares dropping nearly 10% during the trading day Feb. 28. Olaplex presented a net income of $33.6 million or 5 cents per diluted share for the quarter that ended Dec. 31, down from Read More →
Procore aims for lower net loss, continued high growth in 2023
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
LTC Properties posts fourth-quarter earnings
LTC Properties, the real estate investment trust based in Westlake Village that chiefly invests in senior living and health care properties, announced its fourth-quarter results for the period ending December 31. Net income increased by 39.9%, from $12.7 million to $17.8 million or in terms of diluted earnings per common share, from 32 cents to Read More →
Amgen’s $150 million investment aims to scale, diversify middle-market business
By Mark Alfred Special to the Business Times Thousand Oaks-based Amgen, one of the largest biotechnology companies in the world, invested $150 million into Project Black: an Ariel Investments fund intended to transform middle-market companies into certified minority-owned business enterprises. The fund, managed by Ariel’s private equity subsidiary Ariel Alternatives, is based in Chicago. It Read More →
The Trade Desk outperforms competition to close out fiscal year
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
